Natalie Rodriguez Desalden, MD
Geriatric Medicine · Toa Baja, PRNPI 1942517891
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AstraZeneca at 46.4% of the total. Among geriatric medicine clinicians in PR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 38 payments — averaging $56.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1000
- Pfizer Pharmaceuticals LLC$221
- Abbott$197
- Boehringer Ingelheim$140
- Lilly USA, LLC$125
- Amneal Pharmaceuticals LLC$120
- plus $353 from 4 others
What the payments were for
- Food & beverage$2,156100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 17 | $1,000 |
| Pfizer Pharmaceuticals LLC | 2 | $221 |
| Abbott | 2 | $197 |
| Boehringer Ingelheim | 5 | $140 |
| Lilly USA, LLC | 1 | $125 |
| Amneal Pharmaceuticals LLC | 1 | $120 |
| Merck | 3 | $115 |
| E.r. Squibb & Sons, L.L.C. | 1 | $106 |
| Johnson & Johnson | 3 | $70 |
| PBG Puerto Rico LLC | 3 | $62 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,156 in reported general payments places this provider in the 90th percentile of 76 geriatric medicine providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 53 | $52,496 |
| XareltoRivaroxaban | 46 | $47,140 |
| FarxigaDapagliflozin Propanediol | 29 | $34,349 |
| JanuviaSitagliptin Phosphate | 23 | $26,911 |
| SynthroidLevothyroxine Sodium | 214 | $23,835 |
| JardianceEmpagliflozin | 22 | $19,652 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 25 | $17,893 |
| TrulicityDulaglutide | 12 | $11,786 |
| Candesartan-HydrochlorothiazidCandesartan/Hydrochlorothiazid | 57 | $11,185 |
| LantusInsulin Glargine,hum.Rec.Anlog | 86 | $9,264 |
| Breo ElliptaFluticasone/Vilanterol | 21 | $8,689 |
| Lidocaine | 26 | $7,067 |
| Atorvastatin Calcium | 294 | $3,964 |
| Candesartan Cilexetil | 26 | $3,871 |
| Famotidine | 286 | $3,387 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $70 | $47,14046 claims |
| Boehringer IngelheimJardiance, Trijardy Xr | $140 | $37,54547 claims |
| AstraZenecaFarxiga | $1,000 | $34,34929 claims |
| MerckJanuvia | $115 | $26,91123 claims |
| Lilly USA, LLCTrulicity, Humalog | $125 | $14,85540 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $120 | $1,769138 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 76 geriatric medicine providers in Puerto Rico.
Other geriatric medicine in Toa Baja
- Ubaldo Santiago BuonoSan Juan$5K
- Ismael Toro GrajalesBayamon$5K
- Antolin PadillaGuaynabo$4K
- Deric LopezManati$3K
- William Marrero OrtizSan Juan$3K
- Cristina Nevarez de JesusSan Juan$2K
- Daisy Baez FranceschiGuaynabo$2K
- Francisco Torres LozadaPonce$2K
- Carmen MarreroSan Juan$1K
- Ivonne Jimenez VelazquezCarolina$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.